Targeting the membrane-proximal domain of CD33 to maximize the efficacy of natural killer cell-based immunotherapies
Not available.
Saved in:
Main Authors: | Sheryl Y. T. Lim, Frances M. Cole, George S. Laszlo, Margaret C. Lunn-Halbert, Jenny Huo, Junyang Li, Allie R. Kehret, Roland B. Walter |
---|---|
Format: | Article |
Language: | English |
Published: |
Ferrata Storti Foundation
2025-01-01
|
Series: | Haematologica |
Online Access: | https://haematologica.org/article/view/11903 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Natural killer cell engagers for cancer immunotherapy
by: Shahryar Khoshtinat Nikkhoi, et al.
Published: (2025-01-01) -
Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy
by: Ji-Yoon Noh, et al.
Published: (2020-01-01) -
Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies
by: Sandro Matosevic
Published: (2018-01-01) -
Efficacy of natural killer T and gammadelta T cells in mesothelin-targeted immunotherapy of pancreatic cancer
by: Yuankui Zhu, et al.
Published: (2025-02-01) -
Autologous Cytokine-Induced Killer Cell Immunotherapy Enhances Chemotherapy Efficacy against Multidrug-Resistant Tuberculosis
by: Peijun Tang, et al.
Published: (2022-01-01)